being male, with a mean age of 67 years. The mean time from admission to endoscopy was 15.8 hours. The main endoscopic findings were peptic ulcer disease (37%), variceal bleeding (24%) and erosive disease (16%). Six percent of patients had normal endoscopy. The overall rate of 30-day mortality directly related to the UGIB was 7%. The characteristics and the outcomes of the series of patients are described in Table 1 . For the composite endpoint (need for clinical intervention), the AUROCs of GBS, RS, and AIMS65 were, respectively, 0.833, 0.781 and 0.636 in nonvariceal bleeding versus 0.630, 0.543 and 0.620 in variceal bleeding (Figs 1 and 2) . For 30-day mortality, the AUROCs of RS, AIMS65 and GBS were, respectively, 0.864, 0.822 and 0.807 in nonvariceal bleeding and 0.783, 0.826 and 0.793 in variceal bleeding (Figs 3 and 4) .
GBS was the only effective score to predict the need for clinical intervention, but in our population that was only true for patients with nonvariceal bleeding. Regarding mortality, the three scores showed a reasonable performance for both variceal and nonvariceal bleeding, but AIMS65 outperformed GBS.
As in the Korean study, GBS seems superior in its ability to predict need for clinical intervention in the nonvariceal bleeding group. Although we had a similar percentage of patients with variceal bleeding as the Korean study, we could not conclude the same in that specific group of patients. GBS seems the best score to predict need for clinical intervention in patients with nonvariceal bleeding, but we would not recommend its use in the variceal group in the Portuguese population.
As in the Korean population, AIMS65 does not seem good to predict clinical intervention in patients admitted with UGIB in the Portuguese population. However, it outperformed GBS and seems a good score to predict mortality both in the nonvariceal and variceal bleeding patients. In fact, AIMS65 was designed to 
